Metraipolis › archive › dc_07453bfbb4d3

Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumonia — Europe PMC PMID:41460101

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41460101
DOI: 10.1128/aac.01766-25
License (as archived): solo-consultazione
Archived: 2026-11-07T08:48:17.784Z
SHA-256 of the archived text: 42e032d6f0682fec6d49e0d05d488e580a5e6629b0df634dc6bb4ef550db6fd9
Stable URL of this page: https://metraipolis.com/documento/dc_07453bfbb4d3

How to cite

Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumonia — Europe PMC PMID:41460101 — Europe PMC (en), https://europepmc.org/article/MED/41460101 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07453bfbb4d3 (Metraipolis archive dc_07453bfbb4d3, sha256 42e032d6f0682fec6d49e0d05d488e580a5e6629b0df634dc6bb4ef550db6fd9)

BibTeX

@misc{dc07453bfbb4d3,
  title = {Critical threshold target attainment rates for tazobactam combined with piperacillin among patients admitted to the ICU with hospital-acquired pneumonia — Europe PMC PMID:41460101},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41460101},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07453bfbb4d3; sha256 42e032d6f0682fec6d49e0d05d488e580a5e6629b0df634dc6bb4ef550db6fd9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41460101. Agents can read the archived copy with the MCP tool read_document.